{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:45Z","timestamp":1790360265128,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ad Futura Scientific and Educational Foundation of Slovenia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejps.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:59:07Z","timestamp":1429318747000},"page":"25-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Dried blood spots for monitoring and individualization of antiepileptic drug treatment"],"prefix":"10.1016","volume":"75","author":[{"given":"Daniela","family":"Milosheska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Grabnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toma\u017e","family":"Vovk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.04.008_b0005","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.1021\/ac202321q","article-title":"Method of applying internal standard to dried matrix spot samples for use in quantitative bioanalysis","volume":"83","author":"Abu-Rabie","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1365\/s10337-010-1569-y","article-title":"A simple dried blood spot assay for therapeutic drug monitoring of lamotrigine","volume":"71","author":"AbuRuz","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.ejps.2015.04.008_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2011.09.041","article-title":"Therapeutic drug monitoring and LC\u2013MS\/MS","volume":"883\u2013884","author":"Adaway","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2015.04.008_b0020","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4155\/bio.10.158","article-title":"The application of dried blood spot sampling in global clinical trials","volume":"2","author":"Amsterdam","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/B978-0-7020-4086-3.00027-8","article-title":"Use of antiepileptic drugs in hepatic and renal disease","volume":"119","author":"Asconape","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ejps.2015.04.008_b0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ddr.430010716","article-title":"Aspects of the pharmacokinetics and pharmacodynamics of benzodiazepines with particular reference to clobazam","author":"Aucamp","year":"1982","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejps.2015.04.008_b0035","series-title":"Applied Clinical Pharmacokinetics","author":"Bauer","year":"2014"},{"issue":"Suppl 6","key":"10.1016\/j.ejps.2015.04.008_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","article-title":"Pregabalin pharmacology and its relevance to clinical practice","volume":"45","author":"Ben-Menachem","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00614012","article-title":"Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration","volume":"9","author":"Berlin","year":"1975","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0050","unstructured":"Bioequivalence Review(s), Tiagabine, FDA, 1997, <http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/97\/020646ap_gabitril_bioeqr.pdf> (accessed 12.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy","volume":"2","author":"Biton","year":"2006","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.ejps.2015.04.008_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4155\/bio.12.294","article-title":"Heat stabilization of blood spot samples for determination of metabolically unstable drug compounds","volume":"5","author":"Blessborn","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0065","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/clinchem\/23.9.1705","article-title":"Simultaneously obtained skin-puncture serum, skin-puncture plasma, and venous serum compared, and effects of warming the skin before puncture","volume":"23","author":"Blumenfeld","year":"1977","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0070","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(81)92877-4","article-title":"Survival of hepatitis B virus after drying and storage for one week","volume":"1","author":"Bond","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2015.04.008_b0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/bdd.2510130604","article-title":"Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients","volume":"13","author":"Bonneton","year":"1992","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2015.04.008_b0080","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.4155\/bio.12.269","article-title":"Evaluation of glucuronide metabolite stability in dried blood spots","volume":"4","author":"Bowen","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.0013-9580.2005.55204.x","article-title":"Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine","volume":"46","author":"Britzi","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0090","series-title":"An Introduction to Epilepsy","author":"Bromfield","year":"2006"},{"key":"10.1016\/j.ejps.2015.04.008_b0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 28th Annual Report","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.ejps.2015.04.008_b0100","first-page":"103","article-title":"Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures","volume":"6","author":"Brown","year":"2010","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.ejps.2015.04.008_b0105","first-page":"213","article-title":"The absorption and excretion of ethosuximide","volume":"7","author":"Buchanan","year":"1973","journal-title":"Int. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0110","first-page":"172","article-title":"Single- and multiple-dose pharmacokinetics of zonisamide","volume":"37","author":"Buchanan","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/ac303014b","article-title":"Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer","volume":"85","author":"Capiau","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0120","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s13361-013-0678-x","article-title":"Comparison of proteins in whole blood and dried blood spot samples by LC\/MS\/MS","volume":"24","author":"Chambers","year":"2013","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ejps.2015.04.008_b0125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1440-1819.2010.02126.x","article-title":"Is breast-feeding of infants advisable for epileptic mothers taking antiepileptic drugs?","volume":"64","author":"Chen","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejps.2015.04.008_b0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00003088-198917040-00005","article-title":"The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II)","volume":"17","author":"Chiou","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nurt.2006.10.001","article-title":"Stiripentol","volume":"4","author":"Chiron","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejps.2015.04.008_b0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-4347(01)00502-3","article-title":"Determination of antiepileptic drugs in biological material","volume":"767","author":"Chollet","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2015.04.008_b0145","unstructured":"Clinical Laboratory and Standard Institute. Blood collection on filter paper for newborn screening programs; Approved standard-Sixth edition, CLSI document NBS01-A6, Wayne PA, Clinical and Laboratory Standards Institute, 2013, <http:\/\/shopping.netsuite.com\/c.1253739\/site\/Sample_pdf\/NBS01A6_sample.pdf> (accessed 08.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0150","unstructured":"Clinical pharmacology review, Fycompa\u00ae, 2012, <http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/UCM332052.pdf> (accessed 08.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0155","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4155\/bio.13.171","article-title":"In-depth study of homogeneity in DBS using two different techniques: results from the EBF DBS-microsampling consortium","volume":"5","author":"Cobb","year":"2013","journal-title":"Bioanalysis"},{"issue":"Pt 6","key":"10.1016\/j.ejps.2015.04.008_b0160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/000456328402100615","article-title":"A phenytoin assay using dried blood spot samples suitable for domiciliary therapeutic drug monitoring","volume":"21","author":"Coombes","year":"1984","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ejps.2015.04.008_b0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007691-198612000-00005","article-title":"Variable free and total valproic acid concentrations in sole- and multi-drug therapy","volume":"8","author":"Cramer","year":"1986","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0170","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4155\/bio.10.94","article-title":"DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors","volume":"2","author":"D\u2019Arienzo","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0175","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1515\/CCLM.2002.172","article-title":"Clinical utility of free drug monitoring","volume":"40","author":"Dasgupta","year":"2002","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.ejps.2015.04.008_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2015.04.008_b0185","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio.13.156","article-title":"Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions","volume":"5","author":"De Kesel","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0190","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00216-011-5161-6","article-title":"Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications","volume":"402","author":"Deglon","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0195","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.4155\/bio.12.42","article-title":"Rapid LC\u2013MS\/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment","volume":"4","author":"Deglon","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac303205m","article-title":"Dried blood spots: analysis and applications","volume":"85","author":"Demirev","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00216-014-8291-9","article-title":"Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement","volume":"407","author":"den Burger","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0210","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nurt.2006.10.002","article-title":"Lacosamide","volume":"4","author":"Doty","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejps.2015.04.008_b0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003088-198510010-00004","article-title":"Carbamazepine metabolism in man. Induction and pharmacogenetic aspects","volume":"10","author":"Eichelbaum","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0230","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4155\/bio.10.159","article-title":"Pharmacokinetic considerations as to when to use dried blood spot sampling","volume":"2","author":"Emmons","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0235","unstructured":"European public assessment reports - Scientific Discussion, Zonegran\u00ae, 2008, <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000577\/WC500052398.pdf> (accessed 10.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0240","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/bmj.297.6657.1178","article-title":"Filter paper sampling of blood infected with HIV: effect of heat on antibody activity and viral infectivity","volume":"297","author":"Evengard","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2015.04.008_b0245","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.11.337","article-title":"Managing the effect of hematocrit on DBS analysis in a regulated environment","volume":"4","author":"Fan","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/00912700222011210","article-title":"Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers","volume":"42","author":"Ferron","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0255","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1528-1167.2009.02302.x","article-title":"Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy","volume":"50","author":"Filippi","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00313281","article-title":"A prospective randomised trial on the effect of monitoring plasma anticonvulsant levels in epilepsy","volume":"224","author":"Froscher","year":"1981","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejps.2015.04.008_b0265","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/WNL.22.11.1186","article-title":"Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration","volume":"22","author":"Gallagher","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2015.04.008_b0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2011.12.012","article-title":"Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the sample card and prep DBS system","volume":"885\u2013886","author":"Ganz","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2015.04.008_b0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-1211(00)00117-0","article-title":"Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability","volume":"40","author":"Gidal","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejps.2015.04.008_b0280","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/epi.12240","article-title":"Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures","volume":"54","author":"Gidal","year":"2013","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2015.04.008_b0285","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.1365-2125.2001.00770.x","article-title":"Best practice in therapeutic drug monitoring","volume":"52","author":"Gross","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0290","unstructured":"Guideline on bioanalytical method validation: EMEA\/CHMP\/EWP\/192217\/2009, 2012, 2012, <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf> (accessed 08.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0295","unstructured":"Guidance for industry: Bioanalytical method validation. US Department of Health and Human Services, FDA, CDER and CVM, 2001, <http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf> (accessed 05.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0300","unstructured":"Guide to infection prevention for outpatient settings: minimum expectations for safe care, 2014, <http:\/\/www.cdc.gov\/HAI\/pdfs\/guidelines\/Outpatient-Care-Guide-withChecklist.pdf> (accessed 05.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0305","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1528-1157.1995.tb02575.x","article-title":"Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses","volume":"36","author":"Gustavson","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0310","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/clpt.1988.194","article-title":"Pharmacokinetics of vigabatrin: implications of creatinine clearance","volume":"44","author":"Haegele","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2015.04.008_b0315","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.5012\/bkcs.2012.33.5.1681","article-title":"Rapid and sensitive analysis of valproic acid in human red blood cell by LC\u2013MS\/MS","volume":"33","author":"Han","year":"2012","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejps.2015.04.008_b0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0031-6997(24)01329-2","article-title":"Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics","volume":"49","author":"Hinderling","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2015.04.008_b0325","unstructured":"International Association of Therapeutic Drug Monitoring and Clinical Toxicology, 2013, <http:\/\/www.iatdmct.org\/about-us\/about-association\/about-definitions-tdm-ct.html> (accessed 05.12.14)."},{"key":"10.1016\/j.ejps.2015.04.008_b0330","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.4155\/bio.14.185","article-title":"Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review","volume":"6","author":"Jager","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0335","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1528-1157.2000.tb00144.x","article-title":"A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy","volume":"41","author":"Jannuzzi","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0340","first-page":"329","article-title":"Therapeutic drug monitoring of free fraction valproic acid in patients with hypoalbuminaemia","volume":"70","author":"Jansen","year":"2012","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.ejps.2015.04.008_b0345","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1586\/14737175.8.6.929","article-title":"Value of therapeutic drug monitoring in epilepsy","volume":"8","author":"Johannessen","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejps.2015.04.008_b0350","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic drug interactions \u2013 principles and clinical implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0355","series-title":"Antiepileptic Drugs","first-page":"103","author":"Johannessen","year":"2002"},{"key":"10.1016\/j.ejps.2015.04.008_b0360","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0365","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/01.ftd.0000171869.56817.ae","article-title":"Stability of salivary concentrations of the newer antiepileptic drugs in the postal system","volume":"27","author":"Jones","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1099-081X(199701)18:1<17::AID-BDD997>3.0.CO;2-R","article-title":"The distribution of 10-hydroxy carbazepine in blood compartments","volume":"18","author":"Jung","year":"1997","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2015.04.008_b0375","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4196\/kjpp.2011.15.2.67","article-title":"Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring","volume":"15","author":"Kang","year":"2011","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0380","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jps.2600630407","article-title":"Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog","volume":"63","author":"Kaplan","year":"1974","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.04.008_b0385","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jcph.170","article-title":"Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication","volume":"54","author":"Kong","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0390","doi-asserted-by":"crossref","first-page":"e108190","DOI":"10.1371\/journal.pone.0108190","article-title":"Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2015.04.008_b0395","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/ph3061909","article-title":"Therapeutic drug monitoring of the newer anti-epilepsy medications","volume":"3","author":"Krasowski","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejps.2015.04.008_b0400","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cca.2014.06.002","article-title":"Advances in anti-epileptic drug testing","volume":"436","author":"Krasowski","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2015.04.008_b0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5698\/1535-7597-13.6.269","article-title":"Perampanel: a selective AMPA antagonist for treating seizures","volume":"13","author":"Krauss","year":"2013","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.ejps.2015.04.008_b0410","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jpba.2008.09.025","article-title":"Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method","volume":"48","author":"la Marca","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2015.04.008_b0415","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/j.1528-1167.2009.02204.x","article-title":"A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC\u2013tandem mass spectrometry","volume":"50","author":"la Marca","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpba.2010.07.015","article-title":"Rapid assay of rufinamide in dried blood spots by a new liquid chromatography-tandem mass spectrometric method","volume":"54","author":"la Marca","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2015.04.008_b0425","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/j.1552-4604.1983.tb01799.x","article-title":"Pharmacokinetics of stiripentol in normal man: evidence of nonlinearity","volume":"23","author":"Levy","year":"1983","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0430","series-title":"Dried Blood Spots: Applications and Techniques","author":"Li","year":"2014"},{"key":"10.1016\/j.ejps.2015.04.008_b0435","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC\u2013MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2015.04.008_b0440","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4155\/bio.11.219","article-title":"Perforated dried blood spots: a novel format for accurate microsampling","volume":"3","author":"Li","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0445","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/bmc.1572","article-title":"Strategies in quantitative LC\u2013MS\/MS analysis of unstable small molecules in biological matrices","volume":"25","author":"Li","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2015.04.008_b0450","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003088-199936060-00006","article-title":"Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants","volume":"36","author":"Liu","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0455","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1021\/ac2023876","article-title":"Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modification","volume":"83","author":"Liu","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0460","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/00003088-200342120-00002","article-title":"Clinical pharmacokinetics of oxcarbazepine","volume":"42","author":"May","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0465","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1353\/dem.2007.0038","article-title":"What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research","volume":"44","author":"McDade","year":"2007","journal-title":"Demography"},{"key":"10.1016\/j.ejps.2015.04.008_b0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.1994.tb04234.x","article-title":"A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients","volume":"37","author":"McKee","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0475","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4155\/bio.11.202","article-title":"Impact of internal standard addition on dried blood spot analysis in bioanalytical method development","volume":"3","author":"Meesters","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0480","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4155\/bio.12.175","article-title":"Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis","volume":"4","author":"Meesters","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0485","doi-asserted-by":"crossref","first-page":"1631S","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Use of filter paper for the collection and analysis of human whole blood specimens","volume":"131","author":"Mei","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejps.2015.04.008_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9872.1000162","article-title":"An on-card approach for assessment of hematocrit on dried blood spots which allows for correction of sample volume","volume":"4","author":"Miller","year":"2013","journal-title":"J. Anal. Bioanal. Tech."},{"key":"10.1016\/j.ejps.2015.04.008_b0495","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00007691-199812000-00001","article-title":"Clinical pharmacology and therapeutic drug monitoring of zonisamide","volume":"20","author":"Mimaki","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0500","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0090-9556(25)08990-1","article-title":"The metabolic fate of stiripentol in man","volume":"14","author":"Moreland","year":"1986","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.04.008_b0505","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1124\/dmd.30.11.1250","article-title":"Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4\u2032-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes","volume":"30","author":"Nakajima","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2015.04.008_b0510","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1515\/CCLM.2004.245","article-title":"Therapeutic drug monitoring of old and newer anti-epileptic drugs","volume":"42","author":"Neels","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ejps.2015.04.008_b0515","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/j.1552-4604.1982.tb02662.x","article-title":"Phenobarbital pharmacokinetics and bioavailability in adults","volume":"22","author":"Nelson","year":"1982","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0520","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003088-197904020-00002","article-title":"Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications","volume":"4","author":"Neuvonen","year":"1979","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0525","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1248\/bpb1978.15.409","article-title":"Pharmacokinetics of zonisamide; saturable distribution into human and rat erythrocytes and into rat brain","volume":"15","author":"Nishiguchi","year":"1992","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.ejps.2015.04.008_b0530","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/ac403672u","article-title":"Fully-automated approach for online dried blood spot extraction and bioanalysis by two-dimensional-liquid chromatography coupled with high-resolution quadrupole time-of-flight mass spectrometry","volume":"86","author":"Oliveira","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0535","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/rcm.7033","article-title":"Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography\/high-resolution accurate mass spectrometry","volume":"28","author":"Oliveira","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejps.2015.04.008_b0540","first-page":"e50973","article-title":"Dried blood spot collection of health biomarkers to maximize participation in population studies","author":"Ostler","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejps.2015.04.008_b0545","first-page":"155","article-title":"The pharmacokinetic profile of topiramate","volume":"10","author":"Patsalos","year":"1999","journal-title":"Rev. Contemp. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0550","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0555","first-page":"1","article-title":"Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions","volume":"13","author":"Patsalos","year":"2004","journal-title":"Rev. Contemp Pharmacother."},{"key":"10.1016\/j.ejps.2015.04.008_b0560","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1517\/14656566.2012.667803","article-title":"Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate","volume":"13","author":"Patsalos","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejps.2015.04.008_b0565","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0570","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00315422","article-title":"Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia","volume":"39","author":"Patsalos","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0575","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0580","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003088-200038030-00001","article-title":"Is there a role for therapeutic drug monitoring of new anticonvulsants?","volume":"38","author":"Perucca","year":"2000","journal-title":"Clin. Pharmacokinet."},{"issue":"Suppl 4","key":"10.1016\/j.ejps.2015.04.008_b0585","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2005.463007.x","article-title":"An introduction to antiepileptic drugs","volume":"46","author":"Perucca","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0590","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2125.1978.tb01663.x","article-title":"Disposition of sodium valproate in epileptic patients","volume":"5","author":"Perucca","year":"1978","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0595","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","article-title":"Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy","volume":"49","author":"Perucca","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0600","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1528-1157.2002.37201.x","article-title":"Topiramate and metabolic acidosis in infants and toddlers","volume":"43","author":"Philippi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0605","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/00365513.2014.933360","article-title":"Quantification of valproic acid in dried blood spots","volume":"74","author":"Pohanka","year":"2014","journal-title":"Scand J. Clin. Lab. Invest."},{"key":"10.1016\/j.ejps.2015.04.008_b0610","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/acn3.29","article-title":"Model-based lamotrigine clearance changes during pregnancy: clinical implication","volume":"1","author":"Polepally","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ejps.2015.04.008_b0615","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/bmc.2905","article-title":"Development and validation of dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry","volume":"27","author":"Popov","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"Suppl 4","key":"10.1016\/j.ejps.2015.04.008_b0620","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1528-1157.2001.0420s4024.x","article-title":"Pharmacokinetics of levetiracetam","volume":"42","author":"Radtke","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0625","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00003088-199325060-00003","article-title":"Lamotrigine clinical pharmacokinetics","volume":"25","author":"Rambeck","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0630","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00561556","article-title":"Distribution and elimination kinetics of carbamazepine in man","volume":"8","author":"Rawlins","year":"1975","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0635","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eplepsyres.2011.02.002","article-title":"Lamotrigine and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol","volume":"94","author":"Reimers","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejps.2015.04.008_b0640","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-199223040-00003","article-title":"Vigabatrin. Clinical pharmacokinetics","volume":"23","author":"Rey","year":"1992","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0645","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00003088-197904030-00001","article-title":"Clinical pharmacokinetics of phenytoin","volume":"4","author":"Richens","year":"1979","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0650","first-page":"S7","article-title":"Pharmacology and clinical pharmacology of vigabatrin","volume":"2","author":"Richens","year":"1991","journal-title":"J. Child Neurol. Suppl."},{"key":"10.1016\/j.ejps.2015.04.008_b0655","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40262-014-0197-3","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Robijns","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0660","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/bdd.728","article-title":"The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results","volume":"31","author":"Ruiz","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2015.04.008_b0665","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1111\/j.1365-2125.1979.tb04665.x","article-title":"Pharmacokinetics of single and multiple doses of clobazam in humans","volume":"7","author":"Rupp","year":"1979","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0670","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1528-1157.1996.tb00651.x","article-title":"Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy","volume":"37","author":"Sachdeo","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0675","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/rcm.1023","article-title":"Investigation of EDTA anticoagulant in plasma to improve the throughput of liquid chromatography\/tandem mass spectrometric assays","volume":"17","author":"Sadagopan","year":"2003","journal-title":"Rapid. Commun. Mass Spectrom."},{"key":"10.1016\/j.ejps.2015.04.008_b0680","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00216-007-1320-1","article-title":"Current role of LC\u2013MS in therapeutic drug monitoring","volume":"388","author":"Saint-Marcoux","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0685","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/epi.12126","article-title":"Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling","volume":"54","author":"Shah","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0690","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2013.02.005","article-title":"A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots","volume":"923\u2013924","author":"Shah","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2015.04.008_b0695","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.eplepsyres.2005.01.001","article-title":"Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase","volume":"63","author":"Shank","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejps.2015.04.008_b0700","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dta.1646","article-title":"Dried blood spots: concepts, present status, and future perspectives in bioanalysis","volume":"6","author":"Sharma","year":"2014","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.ejps.2015.04.008_b0705","first-page":"16","article-title":"Pharmacogenetics and the concept of individualized medicine","volume":"6","author":"Shastry","year":"2006","journal-title":"Pharm. J."},{"key":"10.1016\/j.ejps.2015.04.008_b0710","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/TCRM.S37317","article-title":"New drug classes for the treatment of partial onset epilepsy: focus on perampanel","volume":"9","author":"Shih","year":"2013","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.ejps.2015.04.008_b0715","unstructured":"Shipping Guidelines for Dried-Blood Spot Specimens, 2012, <http:\/\/www.cdc.gov\/labstandards\/pdf\/nsqap\/Bloodspot_Transportation_Guidelines.pdf> (accessed 05.12.14)."},{"issue":"Suppl","key":"10.1016\/j.ejps.2015.04.008_b0720","first-page":"642","article-title":"Evaluation of the elimination of (14C) felbamate in healthy men","volume":"31","author":"Shumaker","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0725","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/ac8022839","article-title":"Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method","volume":"81","author":"Spooner","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0730","first-page":"1","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","author":"Spooner","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0735","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10408444.2011.650790","article-title":"Dried blood spots in toxicology: from the cradle to the grave?","volume":"42","author":"Stove","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.ejps.2015.04.008_b0740","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1039\/c1ay05160a","article-title":"Analytical methods used in conjunction with dried blood spots","volume":"3","author":"Tanna","year":"2011","journal-title":"Anal. Methods \u2013 UK"},{"key":"10.1016\/j.ejps.2015.04.008_b0745","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00609629","article-title":"Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers","volume":"22","author":"Theisohn","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0750","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1528-1157.1999.tb00777.x","article-title":"Quantification in patient urine samples of felbamate and three metabolites: acid carbamate and two mercapturic acids","volume":"40","author":"Thompson","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0755","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/bio.11.132","article-title":"EBF recommendation on the validation of bioanalytical methods for dried blood spots","volume":"3","author":"Timmerman","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0760","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4155\/bio.13.173","article-title":"Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium","volume":"5","author":"Timmerman","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0765","first-page":"CD002216","article-title":"Therapeutic monitoring of antiepileptic drugs for epilepsy","author":"Tomson","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2015.04.008_b0770","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/epi.12109","article-title":"Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications","volume":"54","author":"Tomson","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0775","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007691-200502000-00004","article-title":"Cost-effectiveness of therapeutic drug monitoring: a systematic review","volume":"27","author":"Touw","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0780","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.4155\/bio.13.172","article-title":"IS addition in bioanalysis of DBS: results from the EBF DBS-microsampling consortium","volume":"5","author":"van Baar","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2015.04.008_b0785","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2014.11.007","article-title":"Dried blood spot assay for the quantification of phenytoin using liquid chromatography\u2013mass spectrometry","volume":"440","author":"Villanelli","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2015.04.008_b0790","first-page":"830","article-title":"Pharmacokinetics and metabolism of gabapentin in rat, dog and man","volume":"36","author":"Vollmer","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2015.04.008_b0795","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/FTD.0b013e31815c15f3","article-title":"Population pharmacokinetic model of carbamazepine derived from routine therapeutic drug monitoring data","volume":"29","author":"Vucicevic","year":"2007","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2015.04.008_b0800","article-title":"The use of mass spectrometry to analyze dried blood spots","author":"Wagner","year":"2014","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ejps.2015.04.008_b0805","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/clinchem\/44.5.1085","article-title":"Standards of laboratory practice: antiepileptic drug monitoring. National academy of clinical biochemistry","volume":"44","author":"Warner","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2015.04.008_b0810","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/j.1528-1167.2010.02771.x","article-title":"Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy","volume":"51","author":"Wegner","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2015.04.008_b0815","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ane.12197","article-title":"Effect of oral contraceptives on lamotrigine levels depends on comedication","volume":"129","author":"Wegner","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ejps.2015.04.008_b0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1535-7511.2009.01336.x","article-title":"Rufinamide: a novel broad-spectrum antiepileptic drug","volume":"10","author":"Wheless","year":"2010","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.ejps.2015.04.008_b0825","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF01061382","article-title":"Kinetics of phenobarbital in normal subjects and epileptic patients","volume":"23","author":"Wilensky","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.008_b0830","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2015.04.008_b0835","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/rcm.5182","article-title":"Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact","volume":"25","author":"Youhnovski","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejps.2015.04.008_b0840","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4155\/bio.13.21","article-title":"Internal standard application to dried blood spots by spraying: investigation of the internal standard distribution","volume":"5","author":"Zimmer","year":"2013","journal-title":"Bioanalysis"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T18:22:15Z","timestamp":1747938135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":168,"alternative-id":["S0928098715001517"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.04.008","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dried blood spots for monitoring and individualization of antiepileptic drug treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}